ラマト・ガンで最高の腎摘出術医師 - トップ4名の医師

Dr. Dorit Zilberman, MD

Senior Urologist & Leading Specialist – Sheba Medical Center

Pioneer in Robotic Urologic Oncology & Minimally Invasive Surgery

Dr. Dorit Zilberman is a highly experienced urologist and one of the pioneers of robotic and minimally invasive urologic surgery in Israel, with over 20 years of clinical experience.

She is a senior specialist at Sheba Medical Center, recognized for her expertise in urologic oncology, robotic surgery, and endourology, and has been consistently named among Israel’s Best Doctors (Forbes 2024).

Areas of Expertise

• Urologic Oncology (Key Focus)
  Treatment of kidney, bladder, and prostate cancers using advanced minimally invasive techniques:
•  
• Robotic & Laparoscopic Surgery
•  
  • Da Vinci robotic surgery pioneer at Sheba
  • Precision tumor removal with minimal trauma
  • Faster recovery and improved functional outcomes
  •  
• Endourology & Stone Disease
•  
  • Advanced kidney stone treatment (laser lithotripsy)
  • Endoscopic, minimally invasive procedures
• General Urology
  Prostate conditions, urinary tract disorders, and bladder dysfunction

Innovation & Surgical Excellence

Dr. Zilberman is known for integrating cutting-edge surgical technologies with a patient-focused approach. She specializes in:

• Minimally invasive, organ-preserving procedures
• Robotic precision surgery for complex tumors
• Advanced laser technologies for stone disease

She completed advanced training in Robotic Laparoscopic Surgery and Endourology at Duke University Medical Center, one of the leading centers in minimally invasive surgery.

Leadership & Academic Roles

• Senior Clinical Lecturer, Tel Aviv University
• Leading Specialist, Department of Urology, Sheba Medical Center

Dr. Zilberman is actively involved in training medical students and future surgeons, contributing to the next generation of urologic specialists.

Research & Recognition

• Author of 160+ scientific publications
• Contributor to leading research in urologic oncology and robotic surgery
• Recipient of prestigious awards from Israeli and American Urological Associations
• Recognized in Forbes Israel Best Doctors List (2024)

Professional Memberships

• Israeli Urological Association
• American Urological Association
• European Association of Urology
• Endourological Society

Dr. Zilberman is dedicated to delivering advanced, personalized care, combining extensive experience, innovative surgical techniques, and a minimally invasive approach to achieve the best possible outcomes while ensuring faster recovery and improved quality of life.

Jair Bar, MD, PhD, Professor

Thoracic Oncologist | Deputy Director of Cancer Center | Lung Cancer Specialist

Areas of Expertise

Professor Jair Bar specializes in thoracic oncology, with a strong focus on advanced lung cancer treatment and translational research:

Lung Cancer (non-small cell and advanced stages)

Thoracic Oncology

Medical Oncology & Radiotherapy

Molecular Biology & Genetics in Cancer

Immunotherapy and Resistance Mechanisms

Translational Oncology Research

About the Doctor

Professor Jair Bar is a leading thoracic oncologist and serves as the Deputy Director of the Cancer Center at Sheba Medical Center.

He also heads the Thoracic Oncology Unit, where he focuses on the treatment of lung cancer using advanced systemic therapies, including immunotherapy and targeted treatments.

In addition to his clinical work, Prof. Bar leads a research laboratory dedicated to studying resistance to immunotherapy, contributing to the development of more effective cancer treatment strategies.

He combines clinical expertise with cutting-edge research, ensuring that patients benefit from the most up-to-date therapeutic approaches.

Clinical Approach

Personalized cancer treatment based on molecular and genetic profiling

Integration of immunotherapy, targeted therapy, and radiotherapy

Multidisciplinary decision-making for complex cases

Focus on improving survival outcomes and quality of life

Positions

Deputy Director, Cancer Center, Sheba Medical Center

Head of Thoracic Oncology Unit

Chair, Israel Lung Cancer Group (since 2003)

Senior Lecturer, Tel Aviv University

Professional Memberships

Member of Israel Society of Clinical Oncology and Radiotherapy

Member of American Society of Clinical Oncology

Member of American Association for Cancer Research

Education and Training

MD, Hebrew University of Jerusalem (Hadassah Medical School)

PhD in Molecular Biology, Weizmann Institute of Science

Board Certifications

Medical Oncology

Radiotherapy Oncology

Research & Publications

Professor Bar is actively involved in translational and clinical research, with publications focused on lung cancer biology and treatment, including:

Cancer metabolism in lung cancer based on exhaled breath analysis

Angiogenesis inhibition strategies in lung cancer therapy

He continues to contribute to advancing precision oncology and immunotherapy approaches in thoracic cancers.

Dr. Nir Kleinmann, MD, directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is an expert in minimally invasive urology and urologic oncology. His focus is the kidney and upper urinary tract. He was named among Israel’s Best Doctors for 2025–2026 by Forbes and ResultMed.

He is a pioneer of kidney‑sparing laser surgery. He uses a dual‑laser system with neodymium and holmium for complex tumors. His expertise includes UTUC, kidney and prostate cancer, kidney stones, and BPH.

His research includes the OLYMPUS trial on chemoablation for UTUC. He has more than 60 publications.

He is an Israeli board‑certified urologist. He is a Fellow of the American Endourology Society and a member of the Israeli Urological Association and the EAU. He completed fellowships in Endourology and Minimally Invasive Surgery at Thomas Jefferson University. He also completed a fellowship in Kidney Cancer Research at McMaster University.

Dr. Barak Rosenzweig, MD

Director, Urological Oncology Service – Sheba Medical Center

Expert in Urologic Oncology & Advanced Robotic Cancer Surgery

Dr. Barak Rosenzweig is a leading uro-oncologic surgeon with nearly 20 years of clinical experience, specializing in the treatment of complex urologic cancers using advanced robotic and minimally invasive techniques.

As Director of the Urological Oncology Service at Sheba Medical Center, he is recognized for delivering high-precision cancer surgery with a strong focus on organ preservation and optimal patient outcomes. He has been named among Israel’s Best Doctors (Forbes) for his excellence in urologic oncology.

Areas of Expertise

• Urologic Oncology (Primary Focus)
• 
  Prostate cancer, kidney tumors, bladder cancer, testicular cancer, upper urinary tract tumors
•  
• Robotic & Minimally Invasive Surgery
•  
  • Robotic radical prostatectomy
  • Partial nephrectomy (kidney-sparing surgery)
  • Advanced laparoscopic cancer procedures
  •  
• Advanced Diagnostics
•  
  • MRI-guided fusion biopsy for precise prostate cancer detection
  • Personalized surgical planning based on advanced imaging

International Training & Surgical Excellence

Dr. Rosenzweig completed advanced fellowship training in Urological Oncology at Memorial Sloan Kettering Cancer Center, one of the world’s most prestigious cancer centers, where he trained with leading experts in robotic cancer surgery.

His approach focuses on:

• Maximizing cancer control while preserving organ function
• Minimally invasive techniques for faster recovery
• Precision-driven, individualized treatment strategies

Leadership & Academic Roles

• Director, Urological Oncology Service, Sheba Medical Center
• Senior Physician, Department of Urology
• Clinical Senior Lecturer, Tel Aviv University
• Graduate, Sheba Talpiot Medical Leadership Program

Research & Recognition

Dr. Rosenzweig is an active researcher with an exceptional academic record:

• 200+ scientific publications in leading journals
• Research focused on urologic cancers, surgical outcomes, and precision oncology
• Recognized in Forbes Israel Best Doctors List

Clinical Approach

Dr. Rosenzweig is known for combining world-class surgical expertise with a patient-centered approach, focusing on:

• Early and accurate diagnosis
• Personalized treatment planning
• Minimally invasive, high-precision surgery
• Preserving quality of life alongside effective cancer control

Dr. Rosenzweig provides advanced, compassionate, and highly individualized care, offering patients access to cutting-edge cancer treatments and internationally recognized expertise at one of the world’s leading medical centers.